TrianglePUBLICATIONS · 38460729
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Transplant Cell Ther
- Publication date
- 2024 May
- First author
- Prete A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Prete A
- type
- Author
- name
- Lanino E
- type
- Author
- name
- Saglio F
- type
- Author
- name
- Biffi A
- type
- Author
- name
- Calore E
- type
- Author
- name
- Faraci M
- type
- Author
- name
- Rondelli R
- type
- Author
- name
- Favre C
- type
- Author
- name
- Zecca M
- type
- Author
- name
- Casazza G
- type
- Author
- name
- Porta F
- type
- Author
- name
- Luksch R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Prete A
- type
- Author
- name
- Lanino E
- type
- Author
- name
- Saglio F
- type
- Author
- name
- Biffi A
- type
- Author
- name
- Calore E
- type
- Author
- name
- Faraci M
- type
- Author
- name
- Rondelli R
- type
- Author
- name
- Favre C
- type
- Author
- name
- Zecca M
- type
- Author
- name
- Casazza G
- type
- Author
- name
- Porta F
- type
- Author
- name
- Luksch R
- type
- Author
- bibliography ids
- nci-bib-323adee99d751ca31ec9ee76
- book metadata
- content sha256
- 5b4848f15f7869ae1bbfa48e71155d2906198085b9355a93a168883109d25e11
- document type
- citation
- dois
- 10.1016/j.jtct.2024.03.002
- electronic publication date
- display
- 2024 Mar 7
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38460729
- immutable id
- pubmed:38460729@5b4848f15f7869ae1bbfa48e71155d2906198085b9355a93a168883109d25e11
- journal
- abbreviation
- Transplant Cell Ther
- issn electronic
- 2666-6367
- issn print
- Source null
- issue
- 5
- name
- Transplantation and cellular therapy
- nlm unique id
- 101774629
- pages
- 530.e1-530.e8
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38460729
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 6315e7dc9cd40157ba7d44e5feaa742f861437dc15589cca1636a3f771e3609b
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 May
- precision
- month
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase II
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Preserved source evidence · Not medical advice